NCT00641472View on ClinicalTrials.gov

Pulmicort Respules(Budesonide Inhalation Suspension) vs Singulair, Children

PHASE4CompletedINTERVENTIONAL

Enrollment

380

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

February 28, 2005

Study Completion Date

February 28, 2005

Conditions

Asthma

Interventions

DRUG

Budesonide inhalation suspension

0.5mg

DRUG

Montelukast Sodium

4mg or 5mg

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY